Filing Flows › Jaguar Health (JAGX) › Q1 2026
Jaguar Health (JAGX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 20, 2026
Jaguar Health (JAGX) reported revenue of $20.3M for the first quarter 2026 (Q1 2026), +816% from a year earlier and +527% from the quarter before. Operating margin was 50.2%, net earnings $8.7M (43.0% of revenue).
Jaguar Health, Q1 2026: revenue $20.3M (+816% year over year), operating margin 50.2%, net earnings $8.7M, operating cash flow $8.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.3M | +527% | +816% |
| Operating profit | $10.2M | — | — |
| Net earnings | $8.7M | — | — |
| Operating cash flow | $8.8M | — | — |
What changed
Revenue was $20.3M in Q1 2026, up 816% year over year and up 527% from the previous quarter. License was the largest line at 94% of revenue. License added $19.0M year over year (up 44086%), 105% of the total change. Mytesi declined 56%.
Operating profit was $10.2M, a 50.2% margin (up 475.7 points year over year). Total costs fell 13% while revenue rose 816%. The fastest-growing cost line was Cost of revenue (+125%). Net earnings were −$7.0M. The effective tax rate was 0.0%.
Operating cash flow was $8.8M, 101% of net income including minority interests. Non-cash charges added back $473K of depreciation and amortization and $155K of share-based compensation. Working capital and other items used $521K.
Questions
What was Jaguar Health's revenue in the first quarter 2026?
Jaguar Health (JAGX) reported revenue of $20.3M for the first quarter 2026 (Q1 2026), +816% from a year earlier and +527% from the quarter before.
Was Jaguar Health profitable in the first quarter 2026?
Operating profit was $10.2M (50.2% of revenue) and net earnings $8.7M.
Source: Jaguar Health 10-Q on SEC EDGAR.